Literature DB >> 21968338

Current status and approaches to developing press-coated chronodelivery drug systems.

Shan-Yang Lin1, Yoshiaki Kawashima.   

Abstract

The past several decades have seen the development of many controlled-release preparations featuring constant release rates to maintain drug concentrations in the human body, regardless of the patient's physiological condition. However, long-term constant drug concentrations in the blood and tissue can cause problems such as resistance, tolerability, and drug side effects. People vary considerably in their physiological and biochemical conditions during any 24 h period, due to the circadian rhythm, and thus, the constant delivery of a drug into the body seems both unnecessary and undesirable. If the drug release profile mimics a living system's pulsatile hormone secretion, then it may improve drug efficacy, and reduce the toxicity of a specific drug administration schedule. Medication and treatments provided according to the body's circadian rhythms will result in better outcomes. This may be provided by a chronopharmaceutical dosage regimen with pulsatile release that matches the circadian rhythm resulting from a disease state, so optimizing the therapeutic effect while minimizing side effects. The press coating technique is a simple and unique technology used to provide tablets with a programmable lag phase, followed by a fast, or rate-controlled, drug release after administration. The technique offers many advantages, and no special coating solvent or coating equipment is required for manufacturing this type of tablet. The present review article introduces chronopharmaceutical press-coated products from a patient physiological needs perspective. The contents of this article include biological rhythms and pulsatile hormone secretion in humans, the reasons for using pulsatile drug delivery for disease treatment, recent chronopharmaceutical preparations appearing on the market, updated compilation of all research articles and press-coated delivery techniques, factors affecting the performance and drug release characteristics of press-coated delivery systems, and recent challenges for the press coating technique. We also provide a brief overview of press-coating approaches intended for chronotherapy. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968338     DOI: 10.1016/j.jconrel.2011.09.065

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  Alleviating the Influence of Circadian Rhythms and Drug Properties to the Release of Paliperidone Gel Matrix Tablets with Compression Coating Technology and Microenvironment Shaping.

Authors:  Zherui Zhang; Shumin Chen; Man Wen; Haibing He; Yu Zhang; Tian Yin; Jingxin Gou; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2022-08-16       Impact factor: 4.026

Review 2.  The mammalian clock and chronopharmacology.

Authors:  Kristine Griffett; Thomas P Burris
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

3.  Development of press-coated, floating-pulsatile drug delivery of lisinopril.

Authors:  Swati C Jagdale; Vishnu M Suryawanshi; Sudhir V Pandya; Bhanudas S Kuchekar; Aniruddha R Chabukswar
Journal:  Sci Pharm       Date:  2014-04-14

4.  Gastroretentive pulsatile release tablets of lercanidipine HCl: development, statistical optimization, and in vitro and in vivo evaluation.

Authors:  Gagganapalli Santhoshi Reddy; Usha Yogendra Nayak; Praful Balavant Deshpande; Srinivas Mutalik
Journal:  ScientificWorldJournal       Date:  2014-11-26

5.  Application of design of experiment for polyox and xanthan gum coated floating pulsatile delivery of sumatriptan succinate in migraine treatment.

Authors:  Swati C Jagdale; Chandrakala R Pawar
Journal:  Biomed Res Int       Date:  2014-10-28       Impact factor: 3.411

6.  Opening the Debate: How to Fulfill the Need for Physicians' Training in Circadian-Related Topics in a Full Medical School Curriculum.

Authors:  Julia M Selfridge; Kurtis Moyer; Daniel G S Capelluto; Carla V Finkielstein
Journal:  J Circadian Rhythms       Date:  2015-11-05

7.  In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency.

Authors:  Ofosua Adi-Dako; Kwabena Ofori-Kwakye; Mariam El Boakye-Gyasi; Samuel Oppong Bekoe; Samuel Okyem
Journal:  J Drug Deliv       Date:  2017-12-24

8.  Optimization studies on compression coated floating-pulsatile drug delivery of bisoprolol.

Authors:  Swati C Jagdale; Nilesh A Bari; Bhanudas S Kuchekar; Aniruddha R Chabukswar
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

Review 9.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

10.  Optimization of Chitosan and Cellulose Acetate Phthalate Controlled Delivery of Methylprednisolone for Treatment of Inflammatory Bowel Disease.

Authors:  Swati Jagdale; Apoorva Chandekar
Journal:  Adv Pharm Bull       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.